News & Events

​Discover the DZ-Lite™ c270: A Compact, Fully Automated Chemistry Analyzer for Modern Labs

6th Nov 2024

The DZ-Lite™ c270 analyzer from Diazyme is designed to bring efficiency, precision, and versatility to today’s clinical chemistry laboratories. With its compact, bench-top design and fully automated functionality, this advanced analyzer delivers reliable results at high speeds—ideal for labs focused on productivity and accuracy. Streamline Your Lab with the DZ-Lite™ c270 O …
read more

Diazyme Goes Green: Transitioning to a Paperless Future with TechDocs

26th Aug 2024

In our ongoing commitment to sustainability, Diazyme Laboratories is taking major steps towards reducing our environmental footprint by going green! One of the key initiatives in this effort is the transition to a paperless system for our product documentation. Simplified Access to Important Documents To achieve this, we’ve launched TechDocs—a new platform that allows users to acc …
read more

Event Recap: Conference Kick Off with Kappa and Lambda - ADLM 2024

15th Aug 2024

At this year's ADLM Lab Expo, Diazyme proudly hosted its first-ever industry workshop, marking a significant milestone for the company. The Diazyme Kappa & Lambda Free Light Chain Key Opinion Leader (KOL) event took place on Tuesday, July 30th, 2024, at the McCormick Place Convention Center. This educational session, titled “Conference Kick-off with Kappa and Lambda: An In-Depth Workshop …
read more

Carolina Liquid Chemistries Corp. and Diazyme Laboratories Announce Partnership

2nd Feb 2023

Carolina Liquid Chemistries Corp. and Diazyme Laboratories, Inc. Announce Partnership Expanding Test Menu on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer, Adding 25 New Assays On Top of Over 50 CLIA Categorized Assays   GREENSBORO, NC — (Jan. 20, 2023) – Carolina Liquid Chemistries Corp. (CLC) and Diazyme Laboratories, Inc. (Diazyme) announce a partnership …
read more

Diazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test

17th Aug 2020

SAN DIEGO, CA - (August 17, 2020) Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA test. The Diazyme IgM test runs on the fully automated DZ-Lite 3000 Plus chemiluminescence analyzer. "Diazyme continues to serve during the public health emergency with innovative products in COVID-19 serology (antibody) testing. The IgM test is t …
read more